Search research articles
Contact Us
Filters
Showing results (51-60 of 56) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 56 results.
Neuropsychobiology
|
January 1, 1995
Cerebral perfusion, electrical activity and effects of serotonergic treatment in obsessive-compulsive disorder. A preliminary study
V Molina, R Montz, M J Pérez-Castejón, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
January 1, 1990
GRF-induced GH response in attention-deficit hyperactivity disorder
R Cacabelos, M Albarrán, C Diéguez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 17, 1998
Technetium-99m-HMPAO in Tourette's syndrome on neuroleptic therapy and after withdrawal
J L Lampreave, V Molina, M J Mardomingo, et al.
The American Journal of Psychiatry
|
October 1, 1996
SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine
V Molina Rodríguez, R Montz Andreé, M J Pérez Castejón, et al.
Schizophrenia Research
|
May 3, 1997
Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study
V Molina Rodríguez, R Montz Andrée, M J Pérez Castejón, et al.
Pharmacology
|
May 22, 2001
Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist
A G Caicoya, M E Beneytez, M Delgado, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 56) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 56 results.
Neuropsychobiology
|
January 1, 1995
Cerebral perfusion, electrical activity and effects of serotonergic treatment in obsessive-compulsive disorder. A preliminary study
V Molina, R Montz, M J Pérez-Castejón, et al.
Methods and Findings in Experimental and Clinical Pharmacology
|
January 1, 1990
GRF-induced GH response in attention-deficit hyperactivity disorder
R Cacabelos, M Albarrán, C Diéguez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 17, 1998
Technetium-99m-HMPAO in Tourette's syndrome on neuroleptic therapy and after withdrawal
J L Lampreave, V Molina, M J Mardomingo, et al.
The American Journal of Psychiatry
|
October 1, 1996
SPECT study of regional cerebral perfusion in neuroleptic-resistant schizophrenic patients who responded or did not respond to clozapine
V Molina Rodríguez, R Montz Andreé, M J Pérez Castejón, et al.
Schizophrenia Research
|
May 3, 1997
Cerebral perfusion correlates of negative symptomatology and parkinsonism in a sample of treatment-refractory schizophrenics: an exploratory 99mTc-HMPAO SPET study
V Molina Rodríguez, R Montz Andrée, M J Pérez Castejón, et al.
Pharmacology
|
May 22, 2001
Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist
A G Caicoya, M E Beneytez, M Delgado, et al.
Page
of 6